These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7953889)

  • 1. [Inhibitors of hematopoiesis: from physiology to therapy].
    Carde P
    Bull Acad Natl Med; 1994 May; 178(5):793-803; discussion 804-6. PubMed ID: 7953889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biomolecules suppressing myelopoiesis].
    Gebran S; Romano E; Soyano A
    Acta Cient Venez; 1992; 43(5):255-68. PubMed ID: 1343739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some hemopoietic negative regulators.
    Axelrad AA
    Exp Hematol; 1990 Feb; 18(2):143-50. PubMed ID: 2406156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet factor 4, reversible inhibitor of megakaryocytogenesis, protector of megakaryocytes during chemotherapy].
    Caen JP; Xi X; Aidoudi S; Fournier S; Schlegel N; Bellucci S; Han ZC
    Bull Acad Natl Med; 1995 Nov; 179(8):1657-70. PubMed ID: 8717183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors.
    Grillon C; Bonnet D; Mary JY; Lenfant M; Najman A; Guigon M
    Stem Cells; 1993 Sep; 11(5):455-64. PubMed ID: 8241956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of cytokine signaling pathways of the transforming growth factor-beta (TGF-beta) family in the regulation of hematopoiesis].
    Fuchs O
    Cas Lek Cesk; 2002 Sep; 141 Suppl():18-22. PubMed ID: 12428417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies].
    Carde P; Chastang C; Goncalves E; Mathieu-Tubiana N; Vuillemin E; Delwail V; Corbion O; Vekhoff A; Isnard F; Ferrero JM
    C R Acad Sci III; 1992; 315(13):545-50. PubMed ID: 1300237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro.
    Eaves C; Eaves A
    Blood Cells; 1994; 20(1):83-93; discussion 93-5. PubMed ID: 7994064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The hemoprotective effect of platelet factor 4 (PF4) and tetrapeptide AcSDKP].
    Han Z; Cai Y; Aidoudi S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):33-5. PubMed ID: 11498842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthetic tetrapeptide AcSDKP protects cells that reconstitute long-term bone marrow stromal cultures from the effects of mafosfamide (Asta Z 7654).
    Genevay MC; Mormont C; Thomas F; Berthier R
    Exp Hematol; 1996 Jan; 24(1):77-81. PubMed ID: 8536796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma FLT3-L levels predict bone marrow recovery from myelosuppressive therapy.
    Blumenthal RD; Lew W; Juweid M; Alisauskas R; Ying Z; Goldenberg DM
    Cancer; 2000 Jan; 88(2):333-43. PubMed ID: 10640965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
    Jackson JD; Yan Y; Ewel C; Talmadge JE
    Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK; Konings AW
    Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of phospholipase C gamma 1 in primitive hematopoiesis during zebrafish development.
    Ma AC; Liang R; Leung AY
    Exp Hematol; 2007 Mar; 35(3):368-73. PubMed ID: 17309817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of c-Mpl ligands in the expansion of cord blood hematopoietic progenitors.
    Piacibello W; Sanavio F; Garetto L; Severino A; Danè A; Gammaitoni L; Aglietta M
    Stem Cells; 1998; 16 Suppl 2():243-8. PubMed ID: 11012196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine mediation of the suppressive effect of ferritin on colony-stimulating factor-1-dependent monocytopoiesis.
    Kreisberg R; Detrick MS; Osmand AP; Moore RN
    J Immunol; 1993 Jun; 150(11):5094-103. PubMed ID: 8496605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation.
    Watanabe T; Brown GS; Kelsey LS; Yan Y; Jackson JD; Ewel C; Kessinger A; Talmadge JE
    Exp Hematol; 1996 May; 24(6):713-21. PubMed ID: 8635527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemokines and the regulation of hematopoiesis].
    Maurer AM; Caen JP; Han ZC
    C R Seances Soc Biol Fil; 1998; 192(5):917-23. PubMed ID: 9871804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory action of the peptide AcSDKP on the proliferative state of hematopoietic stem cells in the presence of captopril but not lisinopril.
    Chisi JE; Wdzieczak-Bakala J; Riches AC
    Stem Cells; 1997; 15(6):455-60. PubMed ID: 9402658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.